Increase market awareness of Valtech’s Cardioband mitral valve reconstruction device in both the US and global marketplaces.
Pascale conducted one-on-one interviews with KOLs in the US and abroad to paint a complete picture of the advantages of Cardioband. Using press releases and media resource guides, we disseminated what we had learned to develop a strong Valtech presence at industry meetings and trade shows. Additionally, we highlighted Cardioband’s utility as a first-line treatment, a contender among other industry options, and we raised investor awareness of the system’s benefits and promise.
Valtech experienced a heightened presence and visibility at global cardiology meetings, including TCT, TVT, London Valve and EuroPCR.